As part of the acute inflammatory response, neutrophils accumulate in the central nervous system af ter injury. Recently, a soluble human recombinant com plement receptor (sCR1; BRL 55730; T Cell Sciences, Inc., Cambridge, MA, U.S.A.) has been developed that
inhibits the activation of both the classical and the alter native pathways of complement. sCR 1 attenuates the ef· fects of the aCUte inl1ammatory response in several mod els of injury outside the central nervous system. The role of complement in traumatic brain injury, however, re mains undefined. We hypothesized that treatment with sCRI would attenuate neutrophil accumUlation in the brain after cerebral trauma. Using a randomized, blinded protocol, 18 anesthetized Sprague-Dawley rats were pre treated with sCRl or saline (control) at both 2 hand 2 min before trauma (weight drop) to the exposed right parietal cortex. A third dose of sCRI (or saline) was given 6 h Outside the central nervous system, complement is activated in traumatic injury, by release of mito chondrial membrane fragments and polynucleotides (GaUinaro et aI., 1992) , Activated complement con tributes to injury extension via the initiation of neu trophil accumulation through several mechanisms (Gerard and Gerard, 1991; Gallinaro et a1., 1992; Mulligan et a!., 1992) . In addition, direct effects of C3a and C5a on histamine release (Gallinaro et al., 1992) and of the C5b-9 membrane attack complex on cell membrane integrity may also occur (Mulli gan et a!., 1992). As part of the acute inflammatory 860 after trauma. Coronal brain sections centered on the site of trauma were obtained at 24 h after trauma and anal yzed for myeloperoxidase (MPO) activity as a marker of neu· trophil accumulation. Complete blood counts with differ ential were obtained before treatment with sCR I and at 24 h after trauma. At 24 h after trauma, brain MPO activity was reduced by 41% in sCRI-treated rats compared with control rats [0.1599 ::t 0.102 versus 0.2712 ± 0.178 U/g (mean ± SD); p = 0.021. The neutrophil count in periph eral blood increased approximately twofold in both groups. Neutrophil accumulation occurring in the brain after trauma is inhibited by sCR I treatment. This suggests that complement activation is involved in the local inflam matory response to traumatic brain injury and plays an important role in neutrophil accumulation in the injured Horner et aI., 1992) and may contribute to injury extension, The specific mechanisms involved in posttraumatic neutrophil accumulation in brain, however, remain to be de fined.
Patients sustaining severe head injury have a sig· nificant decrease in hemolytic activity in total and alternative complement pathways compared with less severely injured patients (indicating prior com plement activation) (Becker et aI., 1987) . Similarly, systemic complement activation has been shown to occur after spinal cord injury (Rebhun et aI., 1991) .
Recently, Pasinetti et a!. (992) showed that mRNA for ClqB is expressed in the peritrauma region after a cortical aspiration lesion in rats. The contribution of local com p lement activation to neutrophil accu· mulation and tissue injury after cerebral trauma, however, has not been investigated.
In the past, two strategies existed to study the effects of complement activation in injury models: pretreatment with cobra venom factor (CYF) and the use of complement-deficient mice (Nilsson and Muller-Eberhard, 1967; Tuomanen et aI., 1986) . Widespread complement activation results from CYF and is associated with the depletion of com plement components, as well as the development of significant systemic effects (the adult respiratory distress syndrome, increased vascular permeabil ity) that make it difficult to use in an experimental setting. The use of complement-deficient mice avoids these systemic effects, but the animals' size makes invasive monitoring (arterial blood pressure, intracranial pressure) impossible.
Recently, a soluble human recombinant mole cule, complement receptor type 1 (sCRI; T Cell Sci ences, Inc., Cambridge, MA, U.S.A.) was devel oped that potently inhibits both the classic and the alternative pathways of complement activation (Weisman et aI., 1990; Fearon, 1991; Mulligan et aI., 1992) . sCRI is similar to the endogenous mem brane-associated complement agonist CR I, which protects erythrocytes against autoinjury during complement activation. It is a reversible inhibitor of complement activation that does not deplete the plasma complement proteins. sCRI is effective in rats and humans and protects in models of inflam mation outside the CNS. Weisman et al. (1990) ad ministered sCRI to rats immediately before coro nary artery ligation. In myocardial specimens of the area at risk (3 h after reperfusion), complement ac tivation was suppressed to undetectable levels, and leukocyte accumulation was decreased by 66%. This was associated with a 45% decrease in myo cardial infarct volume at 7 days (Weisman et aI., 1990) . In addition, Hill et al. (1992) , in a rat model of mesenteric artery ocC\usion/reperfusion, demon strated that pretreatment with sCR 1 reduced intes tinal myeloperoxidase activity (an indicator of neu trophil accumulation) to sham levels. Mulligan et al. (1992) tested sCRI in several models of injury and inflammation. Pretreatment with sCRI (a) reduced neutrophil accumulation by 79% in a rat model of glycogen-induced peritonitis; (b) reduced vascular permeability and hemorrhage by 72% and 71%, re spectively, and reduced neutrophil accumulation by 32% (vs. control) after immune complex-induced al veolitis in rabbits; and (c) attenuated neutrophil ac cumulation, vascular permeability, and edema after cutaneous thermal trauma in rats (Williams et aI., 1985) . The role of complement in traumatic brain injury remains undefined. The hypotheses of this study, then, are that posttraumatic neutrophil accu mulation in rat brain is mediated, in part, by local complement activation, and treatment with sCRl will attenuate posttraumatic brain neutrophil accu mulation.
MATERIALS AND METHODS
This protocol was approved by the University of Pitts burgh Animal Care and Use Committee. Virus-free adult male Sprague-Dawley rats were given free access to food and water throughout the study period. For each experi mental day, each of a pair of rats was randomized to receive sCRI or saline (control; n = 9 per group). Anes thesia was induced in a plastic jar with 4% isoflurane in oxygen. The trachea was intubated with a 14-G angio catheter, and the lungs were mechanically ventilated with 2% isoflurane/66% nitrous oxide/balance oxygen. A fem oral venous catheter (PE 50) was inserted using aseptic technique for the administration of pancuronium (0.1 mg/ kg). A femoral arterial catheter was similarly inserted for continuous monitoring of blood pressure. A rectal tem perature probe was inserted for continuous monitoring and maintenance of temperature at 37.5 ± O.SOC. Benza thine penicillin (33,000 U/kg; Upjohn, Kalamazoo, MI, U.S.A.) and gentamicin (10 mg/kg; Elkins-Sinn, Cherry Hill, NJ, U.S.A.) were administered intramuscularly to prevent any iatrogenic infections. Rats were then given sCRI, 20 mg/kg i.p. (or an equivalent volume of saline for control rats), 2 h before trauma. Two minutes before trauma, a second dose of sCRI, 15 mg/kg i.v. (or an equivalent volume of saline), was given. Using a dental drill, a craniotomy was performed over the right parietal cortex. After a 30-min equilibration period on 0.4% halo thane/66% N20/balance 02' rats were subjected to per cussive (weight drop; 10 g x 5 cm) trauma to the exposed right parietal cortex as described previously (Schoettle et aI., 1990; Biagas et aI., 1992) . Following trauma, the bone flaps were replaced and sealed with dental cement (Kold mount; Vernon Benshoff Co., Albany, NY, U.S.A.), and the scalp incisions closed. Within I h of trauma, all rats were extubated, decannulated, and returned to their cages for food and water ad lib. At 6 h after trauma, rats were reanesthetized in the plastic jar as described, and a femoral venous line was placed using aseptic technique to obtain a blood sample for plasma sCRI levels. Rats were then decannulated, given a third dose of sCRI, 40 mg/kg i.p. (or an equivalent volume of saline), and returned to their cages.
At 24 h after trauma, rats were reanesthetized and un derwent rapid saline cardiac perfusion (200 ml normal saline) via the left ventricle as described previously (Bia gas et aI., 1992). Brains were removed, and 6-mm coronal sections centered on the site of trauma were taken. Sec tions were then analyzed for myeloperoxidase (MPO) ac tivity-a marker of neutrophil accumulation. This assay was developed by Bradley et al. (1982) , to evaluate neu trophil accumulation into inflammatory skin lesions and later modified by Barone et al. (1991) for use in the brain. Briefly, each hemispheric section was homogenized in 8 ml of 50 mM potassium phosphate buffer (pH 6.0; Sigma, St. Louis, MO, U.S.A.) and centrifuged at 2,500 g for 10 min. The supernatant waS discarded, and the pellet was resuspended in 8 ml of 50 mM potassium phosphate buffer. Centrifugation and resuspension in buffer were repeated two additional times as described by Barone ot al. (1991) . Homogenates were pelleted, resuspended in 2.5 ml hexadecyltrimethylammonium bromide (HTAB; 0.5% HTAB in 50 mM potassium phosphate buffer, pH 6.0; Sigma), and subjected to three freeze-thaw cycles (to disrupt the neutrophil primary granules and facilitate the extraction of MPO). After centrifugation, 100 f.ll of super natant was combined with 2.9 ml of 50 mM potassium phosphate buffer (pH 6.0) containing o-dianisidine hydro chloride (0.167 mg/ml; Sigma) and 0.0005% hydrogen per oxide (Sigma) and assayed spectrophotometrically at 460 A for 2 min (in triplicate). MPO activity was calculated as the mean of three readings (Clark et aI., 1994) . One unit of MPO activity was defined as that which degrades 1 f.lmol of peroxide in 1 min.
Separate studies were performed to ensure that sCR 1 did not directly inhibit the MPO assay. Peritoneal neutro phils were isolated from rats (n = 3) as described previ ously (Schoettle et aI., 1990) , sCRI was added at a range of concentrations between 0 and 915 f.lg/ml, and the MPO assay was performed.
An arterial blood gas sample (0.4 ml) was obtained be fore trauma to verify normal blood gas values and hemat ocrit. In addition, complete blood counts with differential (0.5 mt) were obtained from peripheral blood samples of each rat before treatment with sCRl (or saline) and at 24 h after trauma. Plasma samples (I ml of whole blood) for sCRl were obtained before treatment and at 6 and 24 h after trauma. Plasma samples were stored at -70°C and shipped on dry ice to T Cell Sciences for measurement of sCRl levels by ELISA (Yeh et aI., 1991) . Each sample was analyzed in triplicate.
All data are presented as mean ± SD. Comparisons were made using unpaired or paired two-tailed Student's t test or one-way analysis of variance (ANOV A), where appropriate.
RESULTS
Two rats (one control and one treated) died as a result of mechanical difficulties unrelated to treat ment. Thus, eight rats in each group survived to complete the protocol. Physiologic data (rectal tem perature, mean arterial blood pressure, hematocrit, and blood gas values) were recorded for each ani mal. There were no differences between groups for any of these variables (data not shown).
At 24 h after trauma, brain MPO activity was reduced 41 % in sCR I-treated rats compared with controls ( Fig. 1) . There was no difference in MPO activity of isolated rat peritoneal neutrophils in the presence of a wide range of concentrations of sCR 1 , including concentrations fivefold higher than the observed sCRI plasma concentration [NS, p = 0.74 (ANOYA); Table 1 ]. Complete blood counts with leukocyte differen tial were obtained from peripheral blood samples befote treatment (saline or sCR1) and 24 h after trauma (Table 2) . Absolute neutrophil count in creased approximately twofold in both groups (p < 0.05 vs. respective "before-trauma" value). Abso lute lymphocyte count and hematocrit decreased by 24 h in both groups (p < 0.05 vs. respective before trauma value). There were no differences between sCRl-treated and control groups for any hemato logic variable in peripheral blood samples at any given time point.
Plasma levels of sCRI were increased (p < 0.05 vs. baseline) only in sCRl-treated rats. The levels observed were 162 ± 32 versus 1 ± 1 j.Lg ml-I (p < 0.05) in treated and untreated rats, respectively, at 6 h posttrauma. Similar results were observed at 24 h posttrauma, 161 ± 23 versus 0 ± 0 j.Lg ml-1 (p < 0.05) in treated and untreated rats, respectively. An sCRI level �5 j.Lg/ml completely inhibits both the classical and the alternative pathways in rats (un published data; T Cell Sciences).
DISCUSSION
Previous studies in our laboratory have demon strated that neutrophils accumulate in rat brain as part of the acute inflammatory response to trau matic brain injury beginning between 4 and 8 h post trauma (Schoettle et aI., 1990; Biagas et aI., 1992; Clark et aI., 1994) . Horner et al. (1992) assessed MPO activity in the same model of traumatic brain injury and confirmed our findings of early neutro phil accumulation; they also observed that neutro phil accumulation in the brain peaks at 24 to 48 h posttrauma. We have subsequently shown that neu trophil accumulation in the brain was markedly in hibited by prior neutrophil depletion (Biagas et aI., WBC, total white blood cell count; ANC. absolute neutrophil count; ALC, absolute lymphocyte count; Hct, hematocrit.
" p < 0.05 for each variable versus respective "before-trauma" value. b p = 0.08. 1992). Major increases in expression of the comple ment component ClqB mRNA are observed in the peritrauma region of rats after cortical aspiration lesion and in many brain structures after systemic kainic acid injection (Pasinetti et aI., 1992) . Acti vated complement can potentiate neutrophil accu mulation through (a) upregulation of adhesion re ceptors, (b) chemotactic and stimulatory effects of C3a and C5a on neutrophils (Gerard and Gerard, 1991) , and (c) stimulation of cytokine production (Gallinaro et aI., 1992; Mulligan et aI., 1992) . Williams et al. (1985) showed that direct infusion of C5a into the hypothalamus produces neutrophil in filtration within 6 h. Before our study, however, the contribution of complement activation to neutrophil accumulation after traumatic brain injury had not been determined.
Supporting our hypotheses, we have demon strated that in rats treated with sCR I, brain neutro phil accumulation in the traumatized hemisphere is decreased by 41% (as measured by brain MPO ac tivity) compared with that in vehicle-treated con trols. This occurred independently of any signifi cant effects on circulating neutrophil count between the two groups. These data suggest that comple ment is involved in the local acute inflammatory response to cerebral trauma including a role in neu trophil accumulation. Our data support the findings of Pasinetti et al. (1992) and Williams et al. (1985) . This degree of inhibition of neutrophil accumulation is similar to that seen in models of trauma outside the CNS, in animals pretreated with sCRI (Weis man et aI., 1990; Mulligan et aI., 1992) and in ani mals pretreated with CVF (Katori et aI., 1989; Friedl et aI., 1991) . This suggests that the contribu tion of local complement activation in traumatic brain injury is similar to that observed after trauma outside the CNS.
Although we demonstrated significant inhibition of neutrophil accumulation at 24 h posttrauma with sCRI treatment, further studies are needed to prove that the effect represents a sustained inhibition rather than a delay of accumulation. In a rabbit meningitis model, neutrophil accumulation into ce rebrospinal fluid was delayed only by complement depletion with CVF (Tuomanen et aI., 1986) . How ever, even delaying posttraumatic neutrophil accu mulation could be beneficial.
Immunohis' tochemical studies could be per formed to prove that this treatment effect is limited to neutrophils and not partly an effect of sCRl on posttraumatic monocyte accumulation. Monocyte accumulation, however, does not peak until about 1 week posttrauma in the weight-drop model (Horner et aI., 1992) , suggesting that the observed effect of sCR 1 is on neutrophils at 24 h in our study. In ad dition, it is possible that some of the MPO signal in the brain represents transit of neutrophils through brain tissue rather than accumulation. Immuno chemical studies could resolve this point.
We confirmed our previous results of an increase in circulating absolute neutrophil count 24 h post trauma (Schoettle et aI., 1990; Biagas et aI., 1992) , and this is similar to that observed in humans after head injury. The lack of an effect of sCRl on the increase in absolute neutrophil count in the sys temic inflammatory response suggests the partici pation of mechanisms other than complement acti vation for the increase, such as demargination or bone marrow release of neutrophils as a result of systemic catecholamine release after trauma (Dav ies et aI., 1984) . In contrast, we speculate that pre treatment with sCRl prevents the local generation of complement-associated neutrophil chemotaxins and attenuates the accumulation of neutrophils at the site of trauma.
Total white blood cell count decreased about 30% in treated and control rats at 24 h posttrauma (p < 0.05 and p = 0.08 vs. baseline, respectively). This represented a decrease in absolute lymphocyte count. Stress associated with surgery or severe traumatic brain injury, sustained effects of anesthe sia, or other factors could account for this. How ever, the effect was of a similar magnitude in both groups and has been observed previously in this model (Uhl et aI., 1994) .
The effects of inhibition of neutrophil accumula tion or complement activation after cerebral trauma on clinically relevant outcome variables, including the development of cerebral edema, remain un· clear. However, recent studies suggest a contribu tion of neutrophils to delayed hyperemia after cere bral trauma (Uhl et aI., ]994) and to ultimate infarct siz.e in models of cerebral ischemia (del Zappa el aI., 199]; Chopp et aI., 1992) . Inhibition of neutro phil accumulation by sCR I in this mechanistic study suggests that complement is involved in the acute inflammatory response to traumatic brain in jury. Further studies of the effect of sCRl on out come variables after cerebral trauma are warranted.
